Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celsius Holdings, Inc.CELH · Entity 3658 | Director | August 07, 2026 | August 11, 2026 |
| Taylor Morrison Home CorpTMHC · Entity 28500 | Director | May 22, 2025 | May 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celsius Holdings, Inc.
Report date August 07, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 3,812 |
Reported balance
After 2026-08-07 transaction · row 1
1 source rowRow 1 · 2026-08-07 · Grant · Acquired 3,812 · Balance 3,812 F1: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs reflect the pro-rata portion of the annual director equity grant for 2026 beginning on Mr. Previn's date of election to the Board and vest in full on February 27, 2027, which is the date of vesting for all 2026 director equity awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs reflect the pro-rata portion of the annual director equity grant for 2026 beginning on Mr. Previn's date of election to the Board and vest in full on February 27, 2027, which is the date of vesting for all 2026 director equity awards.
Taylor Morrison Home Corp
Report date May 22, 2025 · Filed May 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,096 |
Reported balance
After 2025-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-22 · Grant · Acquired 3,096 · Balance 3,096 F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3: The restricted stock units were granted to Mr. Previn in accordance with the Taylor Morrison 2013 Omnibus Equity Award Plan, as amended. F2: The restricted stock units shall be vested upon the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Company's annual meeting of stockholders immediately following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock.
F2: The restricted stock units shall be vested upon the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Company's annual meeting of stockholders immediately following the date of grant.
F3: The restricted stock units were granted to Mr. Previn in accordance with the Taylor Morrison 2013 Omnibus Equity Award Plan, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2026 Filed Aug 11, 2026 21:37 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock, $0.001 par value per share | 3,812 | $27.77 | $105,859.24 |
DisclosureSEC source: 0001628280-26-055828 · wk-form4_1786484226.xml · nonDerivative · entry 1 Previn Fletcher F · CIK 0002055902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,812 F1 · shares: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs reflect the pro-rata portion of the annual director equity grant for 2026 beginning on Mr. Previn's date of election to the Board and vest in full on February 27, 2027, which is the date of vesting for all 2026 director equity awards. Read SEC document |
| May 22, 2025 Filed May 27, 2025 22:58 UTC | Taylor Morrison Home Corp TMHC · Entity 28500 | GrantRestricted Stock Units · Derivative | 3,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-077975 · ownership.xml · derivative · entry 1 Previn Fletcher F · CIK 0002055902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,096 Underlying: Common Stock · 3,096 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · price: The restricted stock units were granted to Mr. Previn in accordance with the Taylor Morrison 2013 Omnibus Equity Award Plan, as amended. F2 · derivative.exercise_date: The restricted stock units shall be vested upon the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Company's annual meeting of stockholders immediately following the date of grant. F2 · derivative.expiration_date: The restricted stock units shall be vested upon the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Company's annual meeting of stockholders immediately following the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.